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Objectives: To define risk factors associated with the development of abdominal aortic aneurysm (AAA) in a population-
based case-control study.
Material andMethods:Thirty-five patients found to have AAA at screening were compared with 140 age- and sex-matched
controls. Three distinct comparisons were made. Current risk factors in both cohorts were compared. Because data were
also available for both cohorts from a study conducted 12 years previously, a historical comparison was made between risk
factors identified at the time of this initial evaluation. A longitudinal comparison was made between historical and current
risk factors.
Results: Elevated low-density-lipoprotein cholesterol, total cholesterol, and triglyceride levels 12 years before AAA
screening were associated with current AAA with an odds ratio (OR) of 2.3 (95% confidence interval [CI], 1.2 to 4.4);
OR, 1.9 (95% CI, 1.3 to 2.8); and OR, 1.9 (95% CI,1.2 to 3.1)/mmol/L, respectively. Current variables assessed at AAA
screening that were associated with AAA were: A history of atherosclerotic disease, OR, 3.8 (95% CI, 1.7 to 8.5); having
a first-degree relative with AAA, OR, 4.4 (95% CI, 1.5 to 13.0); current smoking, OR, 5.2 (95% CI, 1.6 to 16.8);
high-density-lipoprotein cholesterol level, OR, 0.1 (95% CI, 0.02 to 0.7)/mmol/L; and high-sensitivity C-reactive
protein (hsCRP) level, OR, 1.1 (95% CI, 1.01 to 1.2)/mg/L. Hypertension and diabetes were not associated with AAA.
A significant increase of hsCRP over time (12 years) was observed in AAA patients (P  .039) but not among controls.
The variables of a history of atherosclerosis, smoking, and family history of AAA appear to interact synergistically to
increase the prevalence of AAA (P < .001).
Conclusion: Among traditional risk factors for atherosclerosis, some were associated with AAA and others were not,
indicating complex and partly different causes. Inflammation and heredity appear to be important factors in the
development of AAA. (J Vasc Surg 2005;41:390-6.)Several population-based studies have established male
gender, age, smoking, and a family history of abdominal
aortic aneurysm (AAA) as independent risk factors for
AAA.1-9 Although several studies have revealed a strong
association between AAA and atherosclerotic diseases,1-12
reports on possible associations between AAA and estab-
lished risk factors for atherosclerosis such as hypercho-
lesterolemia and hypertension have shown divergent re-
sults.1-4,6-16 Histologic and epidemiologic differences
between AAA and atherosclerosis have further challenged
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390the traditional theory of AAA being a manifestation of
atherosclerosis.17-21
Between 1984 and 1994, all 60-year-old men and
women living in the northern Sweden municipality of
Norsjö were invited to a yearly health survey at their local
health center as part of the Västerbotten Intervention Pro-
gram (VIP). In 1999, after a median time of 12 years, a
screening study of AAA was performed in the same popu-
lation. The hitherto highest prevalence of AAA in a general
population was reported.22
This study investigated the association of atherosclero-
sis and its risk factors, inflammation as well as heredity for
AAA with AAA detected by screening in this population at
high risk of AAA. Historical data obtained from subjects in
the VIP study at age 60 years and data obtained at screening
for AAA at age 65 to 75 years were analyzed in an explor-
ative population-based case-control study.
SUBJECTS AND METHODS
Study population and study flow. In the AAA
screening study,22 a cross-sectional study in 1999, all men
and women living in Norsjö municipality who then were
between 65 and 75 years of age were invited to a health
examination. Of 555 invited, 504 (91%) participated (248
men and 256 women; median age, 70 years). The exami-
nation included an ultrasonography (US) measurement of
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factors, and fasting blood samples, which were stored. After
informed consent, 63 subjects who had a maximum aortic
diameter at US 28 mm were evaluated with computed
tomography (CT).
An AAA was defined as a mean maximum infrarenal
aortic diameter 30 mm,23 measured by US scanning and
CT (ie, US diameter  CT diameter/2 30 mm). Seven
men and one woman had undergone surgery for AAA
before the screening and were excluded from the analysis
because major surgery or lifestyle changes after major sur-
gery may influence the assessed risk factors.24
The study was designed as a case-control study. For
each AAA case, four AAA-free controls, matched for age
and sex but otherwise randomly selected, were assigned
from the AAA screening study population. Random selec-
tion of controls was done with the Statistical Package for
the Social Sciences (SPSS) (PC version 12.0) computer
software package (SPSS, Inc, Chicago, Ill). Separate un-
matched analyses were performed to evaluate the associa-
tion of sex and age with AAA.
In the comparison of risk factor exposure between AAA
cases and controls, three sets of measurements were used:
(1) those from the VIP study, as will be described later,
when the participants were 60 years old (historical data);
(2) measurements from the AAA screening, when subjects
were between 65 and 75 years old (current data); and (3)
for each biochemical parameter, the differences between
current and historical measurement value calculated as the
value from the current measurement subtracted from the
value from the historical measurement ( data). The me-
Figure. Overview of the study design and evaluated
high-sensitive C-reactive protein.dian time between assessments of historical and currentdata was 12 years (mean, 11.6; Q1 to Q3, 10.0 to 14.0).
The study design is displayed in the Figure.
The VIP study,25 an ongoing community intervention
program addressing cardiovascular disease and diabetes,
started in Norsjö in 1984. As part of this program, all men
and women are asked to donate fasting blood samples the
year they become 60 years old to be stored at the Northern
Sweden Medical Research Bank for future research pur-
poses. For all cases and controls, who were identified in the
1999 AAA screening study and who had participated in the
VIP study between 1984 and 1994, frozen plasma samples
were retrieved for the analysis of historical data.
All participants gave their informed consent, and the
study was approved by the Committee of Ethics of Umeå
University.
Risk factor assessment. In the investigation of smok-
ing habits at the 1999 AAA screening, the subjects were
classified as current smokers, ex-smokers, or nonsmokers.
Pack-years were calculated for current and ex-smokers. One
gram of other smoking tobacco, such as pipe-tobacco, was
considered equivalent to one cigarette. Hypertension was
defined as self-reported hypertension with an on-going
pharmacologic treatment. History of atherosclerotic disease
was defined as self-reported coronary heart disease, cere-
brovascular disease, peripheral artery occlusive disease, or a
combination. Diabetes mellitus was defined as a history of
type 1 or type 2 diabetes mellitus , treated either pharma-
cologically or solely controlled by diet. Family history of
AAA was defined as having a first-degree relative such as
parents, siblings, or offspring with a known AAA.
Biochemical laboratory assessment. All blood sam-
actors for abdominal aortic aneurysm (AAA). hsCRP,risk fples were taken after a minimum 4-hour fast. Subjects
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after an overnight fast, whereas samplings at the AAA
screening study could be done at any time during the
working day for practical reasons. The procedure was oth-
erwise identical in both studies, and the same parameters
were analyzed.
Venous blood was taken in ethylenediaminetetraacetic
acid (EDTA) tubes. The plasma samples were snap-frozen
within 1 hour to 20°C and stored at 80°C within a
week. All EDTA plasma for analyses were thawed and
analysed at the same time.
Triglyceride (TG) and total serum cholesterol levels
were analyzed with kits from Roche/Boehringer (Mann-
heim, Germany). Low-density-lipoprotein (LDL) choles-
terol and high-density-lipoprotein (HDL) cholesterol con-
centrations were measured by direct, homogeneous assays
based on detergent treatment of the serum (N-geneous
HDL-c and N-geneous LDL reagents, respectively, from
Genzyme Corp, Cambridge, Mass). High-sensitive C-reac-
tive protein (hsCRP) was measured by a latex-enhanced
immunoturbidimetry assay (Tina-quant CRP [Latex] HS,
Roche Diagnostics GmbH, Mannheim, Germany).
Statistical analysis. The Kolmogorov-Smirnov test
was used to test for normality. Independent samples t test
was used for comparison of normally distributed data, and
the Wilcoxon rank sum test (Mann-Whitney U test) was
used for comparison of nonparametric data. The Fisher
exact test was used for comparison of two proportions. The
paired t test and Wilcoxon signed-rank test were used for
comparison of paired data. To estimate the odds ratio (OR)
for factors related to AAA after adjustment for atheroscle-
rosis, multivariate forward-stepwise logistic regression
models were used with AAA, or no AAA, as a dichotomous
dependent variable. Kendall -b was used to measure asso-
ciations of ranked variables. P  0.05 was considered
significant. Mean values, percentages, and ORs were pre-
sented with 95% confidence intervals (CI). Statistical eval-
uations of the data were done with SPSS computer soft-
ware.
RESULTS
Historical data (1984-1994 VIP study at age 60
years). Significantly lower HDL cholesterol levels and
higher LDL cholesterol, total cholesterol, and TG levels at
age 60 years were observed in the subjects in whom an AAA
was detected in the 1999 AAA screening (AAA patients),
compared with age- and sex-matched subjects who did not
have an AAA (controls). No difference was seen for hsCRP
(Table I).
Current data (1999 AAA screening study at age 65
to 75 years). The frequency of AAA detected at screening
was 12% (95% CI, 6 to 16) in men and 2% (95% CI, 0 to 4)
in women (P .001) when eight patients already operated
on for AAA were excluded. Of 35 AAAs detected, 29 (83%)
were found in men (95% CI, 70 to 96). The OR for male
sex was 5.5 (95% CI, 2.3 to13.8) and for female sex, 0.2
(95% CI, 0.1 to 0.4). Age was associated with AAA in men,
in whom 74% of all AAAs were found in the older half of thepopulation, OR, 1.2 (95% CI, 1.1 to 1.4) per year. The
prevalence was 17% (95% CI, 10 to 24) in men aged 70 to
74 years and 6% (95% CI, 1 to 10) in men aged 65 to 69
years (P  .009). In women, the corresponding propor-
tions were 3% (95% CI, 0 to 6) and 2% (95% CI, 0 to 4)
(P  .50).
A history of atherosclerotic disease was associated with
AAA (P  .001), Table II. An association with hyperten-
sion was observed (P .036) but not with diabetes. There
were more current smokers (P  .034) and smoke years
(P .016) in the AAA group, but no differences were seen
in the number who had ever smoked (P  .34) or pack-
years (P  .28). Serum levels of hsCRP were significantly
higher (P .003) and the HDL cholesterol concentrations
were significantly lower (P  .002) in the AAA group. No
differences were seen for total cholesterol or LDL choles-
terol. The current TG levels are not reported because only
4 hours of fast do not represent fasting TG data.
A family history of AAA was reported in 6% (95% CI, 4
to 9) of the investigated population. Together with two
pairs of brothers with large AAAs detected at screening, the
prevalence of a family history of AAA was significantly
associated with AAA (P  .001). The prevalence of AAA
among those who had a first-degree relative with an AAA
was 30%. In men, the corresponding frequency was 50%
(95% CI, 24 to 76). Thirty-two percent (95% CI, 14 to 51)
of all men with an AAA had a first-degree relative with an
AAA, resulting in an OR of 6.0 (95% CI, 2.0 to 18.0). The
mean AAA diameter was 46 mm (95% CI, 36 to 56) in
those with a first-degree relative with AAA compared with
38 mm (95% CI, 34 to 42) in those with no family history
of AAA (P  .067).
Differences between current (1999) and historical
(1984 to 1994) data ( data). Several variables changed
over time (Table III). However, only the change in hsCRP
differed between the two groups (P  .015), where a
significant increase within the AAA group (P .039) but a
Table I. Historical data in patients with screening
detected abdominal aortic aneurysm and age- and sex-
matched controls*
Historical data
Controls mean
(95% CI)
(n  140)
AAA mean
(95% CI)
(n  35) P
hsCRP (mg/L) 2.3 (1.1-3.5) 2.4 (1.2-3.5) .94
HDL cholesterol
(mmol/L)
1.3 (1.2-1.4) 1.2 (1.1-1.3) .049
LDL cholesterol
(mmol/L)
3.5 (3.3-3.7) 4.2 (3.8-4.5) .001
Total cholesterol
(mmol/L)
6.3 (6.1-6.5) 7.3 (6.7-7.9) .001
TG (mmol/L) 1.7 (1.5-1.9) 2.3 (1.8-2.9) .035
AAA, Abdominal aortic aneurysm; hsCRP, high-sensitive C-reactive pro-
tein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG,
triglyceride.
*Data obtained at the age of 60 years, an average of 11.6 years before AAA
screening.slight decrease within the control group (P  .006) was
; HD
aired
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the AAA group (P  .005) but not within the control
group (P  .11).
Interactions between AAA and risk factors. A his-
tory of atherosclerotic disease was significantly associated with
male sex, hypertension, low HDL cholesterol levels, and high
TG levels at the time of screening as well as with elevated
historical LDL cholesterol levels. For example, 37% of all men
reported a history of atherosclerotic disease compared with
19% of all women (P  .001), and 61% of those reporting a
history of atherosclerotic disease also reported a history of
hypertension compared with 34% of those with no history of
atherosclerotic disease (P .002). Smoking and hsCRP were
also associated: current smokers had a mean hsCRP of 5.3
mg/L compared with 2.6 mg/L for nonsmokers (P .023)
at screening.
After adjustment for atherosclerosis in a logistic regression
model, the following factors were independently associated
with AAA: having a first degree relative with AAA, current
smoking, smoke years, HDL cholesterol and hsCRP level, as
well as historical LDL cholesterol, total cholesterol, and TG
level. Hypertension and historical HDL cholesterol level were
not independently associated with AAA (Table IV). After
adjustment for smoking, hsCRP retained the associations with
Table II. Current data in patients with screening-detected
controls.*
Current data
Controls m
(95% C
(n  14
Atherosclerotic disease 26% (18-3
Treated hypertension 39% (31-4
Diabetes mellitus 12% (6-17
Ever smoked 44% (36-5
Current smoker 9% (4-13
Smoke-years 13.0 (9.9-
Pack-years 8.6 (5.6-
hsCRP (mg/L ) 2.4 (1.8-
HDL cholesterol (mmol/L) 1.3 (1.3-
LDL cholesterol (mmol/L) 3.3 (3.2-
Total cholesterol (mmol/L) 5.4 (5.3-
First-degree relative with AAA 7% (2-11
AAA, Abdominal aortic aneurysm; hsCRP, high-sensitive C-reactive protein
*Data obtained at AAA screening at the age of 65-75 years.
Table III. Differences between current and historical data
and sex-matched controls.*
 data
Controls Mean
(95% CI) n  140
hsCRP (mg/L ) 0.1 (1.3 to 1.1)
HDL cholesterol (mmol/L) 0.0 (0.0 to 0.1)
LDL cholesterol (mmol/L) 0.2 (0.4 to 0.0)
Total cholesterol (mmol/L) 0.9 (1.1 to 0.6)
AAA, Abdominal aortic aneurysm; hsCRP, high-sensitive C-reactive protei
*The mean time between assessments of data was 11.6 years
†Differences between current and historical data within each group, using pAAA in a logistic regression model (P .029).Ninety percent (95% CI, 73 to 98) of all men with an AAA
detected at the screening either had a history of atherosclerotic
disease, had smoked, or had a family history of AAA. Fifty-
nine percent of the investigated male population reported at
least one of these risk factors, and the prevalence of AAA in this
group of men was 18% (95% CI, 12 to 25). The risk of having
an AAA was significantly associated with the number of these
factors present, (P  .001, Kendall -b). The prevalence was
4% (95% CI, 0 to 8) when none of these factors were present,
12% (95% CI, 5 to 19) with one factor, 22% (95% CI, 10 to
35) with two factors, and 57% (95% CI, 8 to 100) with all
three factors present. When either a history of atherosclerotic
disease or a family history of AAA was present, the ORs were
2.8 and 2.9, respectively, compared to 19.6 when both were
present.
DISCUSSION
The association between AAA and atherosclerosis ob-
served in this study is consistent with previous reports.1-12
This relationship, however, is complex and may influence
the interpretation of other associations found. The higher
prevalence of AAA seen in men may partly be explained by
the association of male sex with atherosclerosis. Further-
more, the association with treated hypertension was lost
ominal aortic aneurysm and age- and sex-matched
AAA mean
(95% CI)
(n  35) P
58% (40-75) .001
60% (43-77) .036
9% (0-18) .77
54% (37-72) .34
23% (8-37) .034
20.0 (10.8-29.2) .016
11.5 (5.4-17.5) .28
4.8 (2.2-7.3) .003
1.2 (1.1-1.2) .002
3.5 (3.2-3.7) .39
5.6 (5.3-6.0) .27
29% (13-46) .001
L, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride.
data ) in patients with screening-detected AAA and age-
P†
AAA Mean
(95% CI) n  35 P†
.006 2.5 (0.3 to 5.3) .039
.96 0.0 (0.1 to 0.2) .73
.11 0.6 (1.0 to 0.2) .005
.001 1.6 (2.2 to 0.9) .001
L, high-density lipoprotein; LDL, low-density lipoprotein.
tests.abd
ean
I)
0)
4)
8)
)
3)
)
16.2)
11.6)
3.0)
1.4)
3.5)
5.6)
))(
n; HDwhen the presence of atherosclerosis was taken into the
iable.
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and AAA is consistent with several previous stud-
ies,9,10,12,26-31 whereas others found hypertension to be
associated with AAA.1,3,5-8,16 In the large Aneurysm De-
tection and Management (ADAM) study,2 hypertension
was only marginally associated with AAA. Because many
studies have shown a relationship between hypertension
and AAA, our finding suggests a possible beneficial effect of
antihypertensive treatment.
Smoking has consistently been associated with AAA1-
10,12,14,16 and several studies have found a dose-response
relationship suggesting a causal role for smoking in the
etiology of AAA.1,6,7,10,12 Our finding that current smok-
ing and duration of smoking are the most important smok-
ing variables associated with AAA is consistent with previ-
ous investigations.1,3,6,7,16 Compared with other
population-based studies, smoking was less frequent in
Norsjö, where 9% were current smokers.1-4,6,7
Although associated with atherosclerosis, lower HDL
cholesterol levels at screening remained independently as-
sociated with AAA in this study when atherosclerosis was
added to the model. The literature in this regard is contra-
dictory. In the ADAM study,2 the largest screening study
ever published, high cholesterol levels were independently
associated with AAA in a multivariate analysis including
atherosclerosis. Simoni and coworkers15 found lower HDL
cholesterol levels among 69 patients with screening-de-
tected AAA compared with 1460 subjects found to have a
normal aortic diameter, but no difference was observed in
LDL cholesterol or total cholesterol levels.15 In the
Tromsø study, a strong inverse association with a dose-
response relation was found between HDL cholesterol
levels and AAA6. In a population-based screening study in
Malmö, Sweden, Bengtsson et al27 found no difference in
total cholesterol levels between subjects with or without
AAA.
Two previous prospective studies have assessed risk factors
to develop AAA based on screening-detected AAA. In the
Edinburgh Artery Study,12 only smoking was significantly
Table IV. Adjusted odds ratios* for factors associated wit
Covariates
Historical data obtained at age 60 years (VIP-study)
LDL cholesterol (mmol/L)
Total cholesterol (mmol/L )
TG (mmol/L )
Current data obtained at age 65-75 years (AAA screening study)
Any atherosclerotic disease
First degree relative with AAA
Treated hypertension
Current smoker
Smoke-years
HDL cholesterol (mmol/L )
hsCRP (mg/L )
LDL, Low-density lipoprotein; TG, triglyceride; AAA, abdominal aortic ane
*Adjusted for atherosclerosis with AAA (or no AAA) as the dependent var
forward stepwise (Likelihood ratio) selection method.associated with AAA in 34 individuals with screening-detectedAAA in whom risk factors were assessed 5 years before screen-
ing. The Cardiovascular Health Study9 found a strong associ-
ation of cardiovascular risk factors, including cholesterol, and
AAA. However, risk factors were assessed only 1 to 4 years
before screening and a different AAA definition was used.
In the present study, elevated LDL cholesterol, total
cholesterol, and TG levels at age 60 years were indepen-
dently associated with screening-detected AAA after a me-
dian of 12 years of follow-up. Furthermore, patients with
AAA decreased their LDL cholesterol levels significantly
over time; controls did not. Total cholesterol levels de-
creased significantly among all studied individuals (P 
.001). This decrease was more pronounced among the
AAA patients, but the difference between groups was not
significant (Table IV).
The probable explanation for the observed decrease in
cholesterol levels is changes in lifestyle, especially in nutri-
tion. The prescription of statins has increased in Sweden;
however, aggregated data from the VIP study described a
low frequency of statin treatment in the studied population.
During the years 1994 through 1998, the most relevant
time-period considering the fact that the AAA-screening
took place during the first half of 1999, 15 (2.8%) of the
540 subjects examined were on statin treatment. Although
we lack data on lipid-lowering therapy on the individual
level, this information indicates that statin treatment was
not an important factor explaining the decrease of choles-
terol levels found among cases and controls.
Arterial remodeling associated with atherogenesis was
suggested to be linked with aneurysm development.32,33
Although the results from the present study suggest that
arterial remodelling offers an alternative explanation for the
high prevalence of AAA in the Norsjö population, firm
conclusions could not be made because of the small sample
size in this limited population.
HsCRP was suggested to be a marker for cardiovascular
disease.34 This association is confounded by mutual rela-
tionships of cardiovascular risk factors, including smoking
habits and age.35 The finding in this study that an elevated
ominal aortic aneurysm.
Odds ratio 95% CI P
2.32 / mmol/L 1.23-4.36 .009
1.90 / mmol/L 1.27-2.83 .002
1.91 / mmol/L 1.18-3.09 .008
3.82 1.72-8.49 .001
4.37 1.47-12.97 .008
1.94 0.85-4.46 .12
5.18 1.60-16.84 .006
1.02 / year 1.00-1.04 .035
0.11 / mmol/L 0.02-0.69 .018
1.10 / mg/L 1.01-1.19 .025
; HDL, high-density lipoprotein; hsCRP, high-sensitive C-reactive protein.
Based on sex- and age-matched data in a logistic regression model, usingh abd
urysmhsCRP level is an independent marker for AAA is consistent
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of a significant increase of hsCRP levels over time in AAA
patients is novel. The elevation of hsCRP was equally
pronounced in small and large AAAs, indicating an inflam-
matory process in the early pathophysiologic phase of AAA.
In 1977, Clifton37 suggested an inheritable trait could
cause AAA. The suggested pattern of inheritance was auto-
somal dominance with incomplete penetrance.38 Most
studies on familial incidence of AAA are based on question-
naires or interviews, and13% of patients with an AAA will
exhibit a family history.39-47 In a review of seven studies on
ultrasound screening of siblings of patients with AAA,
Bengtsson and coworkers48 found an average prevalence of
18.6% in brothers and 3.6% in sisters. The corresponding
frequencies in this study were 32% and 17%, but the only
relatives examined were those living in the investigated area
who were 65 to 75 years old. The proportion of familial
AAA in Norsjö might be even greater, had all relatives been
investigated.
Studies on familial incidence are usually based on large
clinical AAAs.39-48 Patients with familial AAAs tend to be
younger44 and may be over-represented among those with
large AAAs. Two population-based cross-sectional studies
on familial incidence of AAA were published previously,1,2
both with lower incidences than in this study. In conclu-
sion, familial AAAs are more common in the Norsjö mu-
nicipality, and the OR for having an AAA when a first-
degree relative had an AAA was higher.1,2 The possible
inherited predisposition observed in this study may have a
higher penetrance, offering an explanation of the high
prevalence found.
Atherosclerosis, smoking, and having a first-degree rel-
ative with AAA were all associated with AAA. The preva-
lence increased with the number of these factors, the OR
being 32 when all three were present. These three factors
may independently be associated with AAA with additional
effect of multiple factors. This observation underlines the
complexity of the disease and the possibility of a gene-
environment interaction.
Several methodologic considerations may have influ-
enced the results and conclusions of this study. Selection
bias was minimized by the population-based design and by
the high attendance rate. The main limitation of this study
is its size; however, significant associations were found. In
cohort studies, it is essential to analyse and report subjects
lost to follow-up but this information was not available for
the original cohort that entered the VIP study. The present
study is therefore not a true cohort study, although the
historical data were collected prospectively. Considering
this limitation it was, however, possible to analyse changes
over time. Self-reporting data are prone to recall bias, and
those not reporting a history of cardiovascular disease may
have atherosclerosis that is not clinically manifested.
CONCLUSIONS
In this explorative study, the risk of having an AAA at
screening was associated with male sex, high age, a historyof atherosclerosis, current smoking, and having a first-
degree relative with AAA.
● Among traditional risk factors for atherosclerosis,
some were associated with AAA; others were not,
indicating complex and partly different etiologic
mechanisms.
● Inflammation may be an important factor in the devel-
opment of AAA.
● Familial AAA was more prevalent than in previous
reports, whereas atherosclerosis and smoking habits
were not more prevalent compared to other popula-
tions.
● An interaction was observed when more than one of
these factors was present, and combinations of factors
seem to be important in the development of AAA.
We thank Professor Göran Hallmans and his staff at the
Northern Sweden Medical Research Bank, Umeå Univer-
sity Hospital, for expert help with the blood samples and
Associate Professor Mats Ögren at the Department of
Surgery, Uppsala University Hospital, for assistance with
the statistical analysis and for valuable suggestions during
revision of the manuscript.
REFERENCES
1. Jamrozik K, Norman P, Spencer C, Parsons R, Tuohy R, Lawrence-
Brown M, Dickinson J. Screening for abdominal aortic aneurysm:
lessons from a population-based study. MJA 2000;173:345-50.
2. Lederle F, Johnson G, Wilson S, Chute E, Hye R, Makaroun M, et al.
and the Aneurysm Detection and Management Veterans Affairs Coop-
erative Study Investigators. The aneurysm detection and management
study screening program. Validation cohort and final results. Arch
Intern Med 2000;160:1425-30.
3. Krohn C, Kullmann G, Kvernebo K, Rosén L, Kroese A. Ultrasono-
graphic screeening for abdominal aortic aneurysm. Eur J Surg 1992;
158:527-30.
4. Pleumeekers H, Hoes A, van der Does E, van Urk H, Hofman A, de
Jong P, et al. Aneurysms of the abdominal aorta in older adults. The
Rotterdam study. Am J Epidemiol 1995;142:1291-9.
5. Kanagasabay R, Gajraj H, Pointon L, Scott A. Co-morbidity in patients
with abdominal aortic aneurysm. J Med Screen 1996;3:208-10.
6. Singh K, Bønaa K, Jacobsen B, Bjørk L, Solberg S. Prevalence of and
risk factors for abdominal aortic aneurysms in a population-based study.
The Tromsø study. Am J Epidemiol 2001;154:236-44.
7. Vardulaki K, Walker N, Day N, Duffy S, Ashton H, Scott A. Quantify-
ing the risk of hypertension, age, sex and smoking in patients with
abdominal aortic aneurysm. Br J Surg 2000;87:195-200.
8. Simoni G, Pastorino C, Perrone R, Ardia A, Gianrossi R, Decian F, et al.
Screening for abdominal aortic aneurysms and associated risk factors in
a general population. Eur J Vasc Endovasc Surg 1995;10:207-10.
9. Alcorn H, Wolfson S, Sutton-Tyrrell K, Kuller L, O’Leary D. Risk
factors for abdominal aortic aneurysms in older adults enrolled in the
cardiovascular health study. Arterioscler Thromb Vasc Biol 1996;16:
963-70.
10. Blanchard J, Armenian H, Friesen P. Risk factors for abdominal aortic
aneurysm: results of a case-control study. Am J Epidemiol 2000;151:
575-83.
11. Newman A, Arnold A, Burke G, O=Leary D, Manolio T. Cardiovascular
disease and mortality in older adults with small abdominal aortic aneu-
rysms detected by ultrasonography: the cardiovascular health study.
Ann Intern Med 2001;134:182-90.
12. Lee A, Fowkes F, Carson M, Leng G, Allan P. Smoking, atherosclerosis
and risk of abdominal aortic aneurysm. Eur Heart J 1997;18:671-76.
JOURNAL OF VASCULAR SURGERY
March 2005396 Wanhainen et al13. Louwrens H, Adamson J, Powell J, Greenhalgh R. Risk factors for
atherosclerosis in men with stenosing or aneurysmal disease of the
abdominal aorta. Int Angiol 1993;12:21-4.
14. Naydeck B, Sutton-Tyrrell K, Schiller K, Newman A, Kuller L. Preva-
lence and risk factors for abdominal aortic aneurysms in older adults
with and without isolated systolic hypertension. Am J Cardiol 1999;83:
759-64.
15. Simoni G, Gianotti A, Ardia A, Baiardi A, Galleano R, Civalleri D.
Screening study of abdominal aortic aneurysm in a general population:
lipid parameters. Cardiovasc Surg 1996;4:445-8.
16. Törnwall M, Virtamo J, Haukka J, Albanes D, Huttunen J. Life-style
factors and risk for abdominal aortic aneurysm in a cohort of Finnish
male smokers. Epidemiology 2001;12:94-100.
17. Norman P, Castleden W, Hockey R. Prevalence of abdominal aortic
aneurysm in Western Australia. Br J Surg 1991;78:1118-21.
18. Lilienfeld D, Gunderson P, Sprofka J, Vargas O. Epidemiology of aortic
aneurysms. I. Mortality trends in the United States, 1951 to 1981.
Arteriosclerosis 1987;7:637-9.
19. Coggon D, Winter P, Martyn C, Inskip H. Contrasting epidemiology
of aortic aneurysm and peripheral vascular disease in England and
Wales. BMJ 1996;312:948.
20. Satta J, Laurila A, Pääkkö P, Haukipuro K, Sormunen R, Parkkila S
, et al. Chronic inflammation and Elastin degradation in abdominal
aortic aneurysm disease: an immunohistochemical and electron micro-
scopic study. Eur J Vasc Endovasc Surg 1998;15:313-9.
21. Patel MI, Hardman DT, Fisher CM, Appleberg M. Current views on
the pathogenesis of abdominal aortic aneurysms. J Am Coll Surg
1995;181:371-82.
22. Wanhainen A, Bjorck M, Boman K, Rutegard J, Bergqvist D. Influence
of diagnostic criteria on the prevalence of abdominal aortic aneurysm. J
Vasc Surg 2001;34:229-35.
23. McGregor J, Pollock J, Anton H. The value of ultrasonography in the
diagnosis of abdominal aortic aneurysm. Scott Med J. 1975;20:133-7.
24. The UK small Aneurysm Trial Participants. Long-term outcomes of
immediate repair compared with surveillance of small abdominal aortic
aneurysms. N Engl J Med 2002;346(19):1445-52.
25. Protokoll från förvaltningsutskottets sammanträde 1984-12-17. [Pro-
tocol from the County council board meeting, Dec 17, 1984]. Umeå:
Västerbottens Läns Landsting. §470.
26. Collin J, Walton J, Araujo L, Lindsell D. Oxford screening programme
for abdominal aortic aneurysm in men aged 65 to 74 years. Lancet
1988;2(8711):613-15.
27. Bengtsson H, Bergqvist D, Ekberg O, Janzon L. A population based
screening of abdominal aortic aneurysm (AAA). Eur J Vasc Surg 1991;
5:53-7.
28. Scott A, Ashton A, Kay N. Abdominal aortic aneurysm in 4237 screened
patients: prevalence, development and management over 6 years. Br J
Surg 1991;78:1122-5.
29. Smith C, Grimshaw M, Paterson S, Shearman P, Hamer D. Ultrasono-
graphic screening for abdominal aortic aneurysm in an urban commu-
nity. Br J Surg 1993;80:1406-9.
30. Lindholm L, Ejlersson G, Forsberg L, Norgren L. Low prevalence of
abdominal aortic aneurysm in hypertensive patients. Acta Med Scand
1985;218:305-1031. Blann A, Devine C, Amiral J, McCollum. Soluble adhesion molecules,
endothelial markers and atherosclerosis risk factors in abdominal aortic
aneurysm: a comparison with claudicants and healthy controls. Blood
Coag Fibrinol 1998;9:479-84.
32. Zarins CK, Xu CP, Glagov S. Aneurysmal enlargement of the aorta
during regression of experimental atherosclerosis. J Vasc Surg 1992;15:
90-8.
33. Zarins CK, Glagov S, Vesselinovitch D, Wissler RW. Aneurysm forma-
tion in experimental atherosclerosis: relationship to plaque evolution. J
Vasc Surg 1990;12:246-56.
34. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-
reactive protein in risk assessment. Am J Med 2004;116 Suppl 6A:9S-
16S.
35. Rhode LE, Hennekens CH, Ridker PM. Survey of C-reactive protein
and cardiovascular risk factors in apparently healthy men. Am J Cardiol
1999;84:1018-22.
36. Koch AE, Haines GK, Rizzo RJ, Radoservich JA, Pope RM, Robinson
PG, et al. Human abdominal aortic aneurysms: immunophenotypic
analysis suggesting an immune mediated response. Am J Pathol 1990;
137:1199-213.
37. Clifton MA. Familial abdominal aortic aneurysms. Br J Surg 1977;64:
765-6.
38. Tilson MD, Seashore MR. Human genetics of the abdominal aortic
aneurysm. Surg Gynecol Obstret 1984;158:129-32.
39. Norrgård Ö, Rais O, A¨ngquist KA. Familial occurrence of abdominal
aortic aneurysms. Surgery 1984;95:650-6.
40. Johansen K, Koepsell T. Familial tendency for abdominal aortic aneu-
rysms. JAMA 1986;256:1934-6.
41. Powell JT, Greenhalgh RM. Multifactorial inheritance of abdominal
aortic aneurysm. Eur J Vasc Surg 1987;1:29-31.
42. Johnston KW, Scobie TK. Multicenter prospective study of nonrup-
tured abdominal aortic aneurysms. I. Population and operative manage-
ment. J Vasc Surg 1988;7:69-81.
43. Cole CW, Barber GG, Bouchard AG, McPhail NV, Roberge C, Wad-
dell WG, Wellington JL. Abdominal aortic aneurysm: consequences of
a positive family history. Can J Surg 1989;32:117-20.
44. Darling RC III, Brewster DC, Darling RC, LaMuraglia GM, Moncure
AC, Cambria RP, et al. Are familial abdominal aortic aneurysms differ-
ent? J Vasc Surg 1989;10:39-43.
45. Majumder PP, St Jean PL, Ferrell RE, Webster MW, Steed DL. On the
inheritance of abdominal aortic aneurysm. Am J Hum Genet 1991;48:
164-70.
46. Verloes A, Sakalihasan N, Koulischer L, Limet R. Aneurysms of the
abdominal aorta: familial and genetic aspects in three hundred thirteen
pedigrees. J Vasc Surg 1995;21:646-55.
47. Lawrence PF, Wallis C, Dobrin PB, Bhirangi K, Gugliuzza N, Galt S,
Kraiss L. Peripheral aneurysms and arteriomegaly: is there a familial
pattern? J Vasc Surg 1998;28:599-605.
48. Bengtsson H, Sonesson B, Bergqvist D. Incidence and prevalence of
abdominal aortic aneurysms, estimated by necropsy studies and popu-
lation screening by ultrasound. Ann NY Acad Sci 1996;800:1-24.Submitted Jun 11, 2004; accepted Jan 2, 2005.
